Brown Advisory’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Brown Advisory’s Portfolio KRTX Stock Details KRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-333,144	Closed	-$105M	–	1302
2023 Q4	$105M	Buy	333,144 +11,059	+3%	+$2.15M	0.15%	122
2023 Q3	$54.5M	Sell	322,085 -1,373	-0.4%	-$258K	0.09%	175
2023 Q2	$70.1M	Buy	323,458 +397	+0.1%	+$85.1K	0.11%	158
2023 Q1	$58.7M	Buy	323,061 +63,499	+24%	+$12.1M	0.1%	172
2022 Q4	$51M	Buy	259,562 +29,649	+13%	+$6.36M	0.09%	186
2022 Q3	$51.7M	Buy	+229,913	New	+$46.5M	0.1%	177

Other funds holding KRTX

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Brown Advisory's KRTX Position: Q1 2024 in Review

Brown Advisory sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 333,144 shares — an estimated $105M sold.

Brown Advisory first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $105M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

Brown Advisory reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
Brown Advisory sold 333,144 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $105M.
Brown Advisory first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
Brown Advisory's Karuna Therapeutics, Inc. Common Stock position peaked at $105M in Q4 2023.
2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Brown Advisory's 13F filing for Q1 2024, filed 24 Apr 2024.